Used in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), this compound plays a key role in modulating biological pathways related to inflammation and pain. It has shown promise in preclinical studies for treating neuropathic pain, inflammatory conditions, and certain cardiovascular diseases by stabilizing endogenous epoxy fatty acids, which have anti-inflammatory and analgesic effects. Due to its ability to cross the blood-brain barrier, it is also investigated for central nervous system disorders. Its structural features enhance metabolic stability and target specificity, making it a valuable scaffold in developing new therapeutic agents.